Generally, these data demonstrated the inhibitory effects of sEV‐mDCs on the type 2 responses partially by acting on the IL‐10/IL‐10Rα axis, further indicating the potential application of the cell‐free therapy of MSC‐sEV in the treatment of allergic rhinitis. Here, IL10RA is linked to allergic rhinitis.